COMMON STOCK TRANSACTIONS |
12 Months Ended |
|---|---|
Apr. 30, 2024 | |
| Equity [Abstract] | |
| COMMON STOCK TRANSACTIONS |
NOTE 5 – COMMON STOCK TRANSACTIONS
A summary of the Company’s compensatory stock activity and related weighted average grant date fair value information for the years ended April 30, 2024 and 2023, are as follows:
In January 2022, the Company awarded shares of common stock to the executive officers of the Company as part of their compensation agreements for 2022. These shares vest monthly over a twelve-month period and are subject to the executive officers continuing to provide service under their compensation agreements. During the years ended April 30, 2024 and 2023, the Company recorded a non-cash compensation expense in the amounts of $ and $. There were unvested shares as of April 30, 2024 and 2023, respectively.
During the year ended April 30, 2023, three non-employee members of the Board were issued shares of common stock pursuant to their Director Letter Agreements (“DLAs”) in respect of their service during that year. The shares were fully vested upon issuance. The Company recorded a non-cash expense of $ and $ for the years ended April 30, 2024 and 2023, respectively. There were unvested shares remaining related to such DLAs as of April 30, 2024 and 2023, respectively.
All shares were issued without registration under the Securities Act in reliance upon the exemption afforded by Section 4(a)(2) of the Securities Act.
There were shares granted, vested or expired during the year ended April 30, 2024.
|